Welcome to our dedicated page for EQUIFAX SEC filings (Ticker: EFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Equifax SEC filings document the company’s operating results, capital structure, governance, and material corporate agreements. Recent Form 8-K reports include quarterly financial-results releases and amendments to the company’s unsecured revolving credit facility involving Equifax and subsidiary borrowers.
Regulatory records also identify Equifax common stock listed on the New York Stock Exchange under EFX. Proxy materials cover annual meeting matters, board and shareholder voting topics, executive compensation, and company discussion of data, cloud technology, security, and EFX.AI within its public-company governance framework.
EQUIFAX INC director Barbara A. Larson reported two compensation-related acquisitions of Phantom Stock Units on 2026-08-10. She received 181 units at $158.72 per unit and 160 units at $180.07 per unit, each unit being the economic equivalent of one share of common stock. These phantom units were elected as deferred compensation in lieu of annual cash retainer fees under the Board of Directors Deferred Compensation Plan and become payable, at her election, upon termination of service as a director.
Equifax Inc. issued $500,000,000 of 5.000% Senior Notes due 2029 and $500,000,000 of 5.650% Senior Notes due 2033 under an Indenture dated July 29, 2026. Both series pay interest semi-annually on February 15 and August 15, beginning February 15, 2027.
The 2029 Notes mature on August 15, 2029 and the 2033 Notes on August 15, 2033. Each series is redeemable at the company’s option at a make-whole redemption price based on the Treasury Rate plus a small spread, with the 2033 Notes callable at par on or after June 15, 2033. Net proceeds of approximately $990.5 million are intended for repayment of borrowings under the company’s commercial paper program.
Equifax CEO Mark W. Begor exercised stock options covering 37,791 shares of common stock at an exercise price of $112.46 per share on 2026-07-24, then sold 37,791 shares in multiple transactions at reported weighted-average prices including $175.8520, $169.8583 and $171.2619 per share, pursuant to a Rule 10b5-1 trading plan adopted on 10/28/2025. He reports 37,792 stock options remaining and additional indirect common stock holdings through several 2-year GRATs.
Mark W. Begor filed a notice of proposed sale of 37,791 shares of common stock, to be sold through Fidelity Brokerage Services LLC on the NYSE on 07/24/2026. The filing lists an aggregate market value of $6,506,254.39 for these shares and notes total shares outstanding of 117,484,896.
The shares are planned to be acquired from the issuer on 07/24/2026 via a stock option exercise paid in cash. The filing also reports that 37,791 shares of common stock were sold previously on 04/24/2026, with gross proceeds of $6,515,210.42.
Equifax Inc. is issuing $500,000,000 of 5.000% senior notes due August 15, 2029 and $500,000,000 of 5.650% senior notes due August 15, 2033. The notes are senior unsecured obligations ranking equally with other unsecured senior debt and structurally subordinated to liabilities of subsidiaries.
Interest is paid semi-annually on February 15 and August 15, beginning February 15, 2027, in minimum denominations of $2,000. Equifax may redeem the notes early at specified make-whole or par prices and must make a repurchase offer at 101% upon a qualifying change of control triggering event.
Net proceeds of approximately $990.5 million will be used to repay borrowings under Equifax’s commercial paper program. As of December 31, 2025, Equifax generated operating revenue of $6.1 billion and net income attributable to Equifax of $660.3 million; as of June 30, 2026, total debt was about $5.5 billion.
Equifax Inc. is conducting an underwritten public offering of two series of senior unsecured notes under its shelf registration. The notes will bear fixed interest, pay semi-annually, and mature on stated future dates; they will be issued in minimum denominations of $2,000 and will not be listed on any exchange. Equifax may redeem the notes before maturity at specified make-whole and par call prices and must offer to repurchase them at 101% of principal plus accrued interest upon a defined change of control triggering event.
The notes rank equally with Equifax’s other senior unsecured debt and are structurally subordinated to liabilities of its subsidiaries, which had $1,221.1 million of liabilities, including $4.5 million of debt, as of June 30, 2026. At the parent level, unsubordinated unsecured debt totaled $5,462.6 million. Net proceeds will be used to repay borrowings under the company’s commercial paper program. For 2025, Equifax generated $6.1 billion of operating revenue and $660.3 million of net income attributable to Equifax.
Equifax Inc. reported solid growth for the quarter ended June 30, 2026, with operating revenue of $1,700.1 million, up 11% from 2025, and first-half revenue of $3,349.0 million, up 12%. Diluted EPS was $1.54 for the quarter (slightly above $1.53 a year earlier) and $2.96 for the first six months versus $2.59.
Operating margin declined to 18.5% from 20.2% as higher royalty costs, increased amortization from prior technology investments and litigation expense offset revenue growth. Results include a $100 million accrual for settling an FCRA-related class action tied to a coding issue, partly offset by a $60 million insurance receivable, for a net charge of about $40 million. Workforce Solutions, U.S. Information Solutions and International all grew, led by USIS Online Information Solutions and Verification Services. Cash from operations was $581.7 million in the first half against capital expenditures of $246.5 million. Total consolidated debt, net, rose to $5,467.1 million, including $1.4 billion of commercial paper, while Equifax repurchased 3.1 million shares for $560.0 million and paid dividends of $1.12 per share in the first half.
Equifax Inc. reported second quarter 2026 revenue of $1.700 billion, up 11% year over year with 10% local currency growth, driven by 7% growth in Workforce Solutions, 17% in U.S. Information Solutions and 8% in International.
Net income attributable to Equifax was $183.9 million, down 4%, while diluted EPS inched up to $1.54 from $1.53. Adjusted net income was $268.6 million and adjusted diluted EPS rose 13% to $2.25, with adjusted EBITDA of $552.1 million and a 32.5% margin, flat versus 2025. Results include a $40.0 million pre‑tax charge for a legal settlement associated with a previously disclosed coding issue.
The company agreed to acquire Mexican credit bureau Círculo de Crédito for an enterprise value of $750 million, targeting closing in the fourth quarter of 2026, and doubled its 2026–2028 AI‑driven cost reduction goal to $150 million. Equifax returned $366 million to shareholders through repurchasing 1.8 million shares for $300 million and paying $66 million in dividends. Full‑year 2026 guidance calls for $6.710–$6.780 billion of revenue, 10.5–11.6% growth, and adjusted EPS of $8.39–$8.69.
MARCUS ROBERT D reported acquisition or exercise transactions in this Form 4 filing.
Equifax Inc. director Robert D. Marcus received a grant of 221 Phantom Stock Units as deferred compensation in lieu of his annual cash retainer fees. Each unit is economically equivalent to one share of Equifax common stock. Following this award, he holds 2,710 phantom stock units. These units are payable, at his election, after his service as a director ends.
Equifax Inc. updated its corporate bylaws to change how shareholders can request a special meeting. Effective June 16, 2026, one or more shareholders must collectively own at least 25% of the voting power of all outstanding shares and have held them for at least one year to request a special meeting, subject to detailed procedural requirements in the amended bylaws. The company also made ministerial clarifications and updates, and the full Amended and Restated Bylaws are filed as an exhibit to this Form 8-K.